Sitemap
- Home
- Nuestro mundo
- Privacy Notice
- Términos de uso
- Clausura de exención de responsabilidades
- Áreas terapéuticas
- Profesionales sanitarios
- Cartera de productos
- Carta de productos
- General
- Publications
- 2023 Congresses
- 2024 Congresses
- Dang U. et al. Age, family history and genetic testing data from myotonic dystrophy patients and carers participating in ENSA survey; P65
- Díaz-Manera J et al. RevEal the burdeN on daily life for myotonic dyStrophy patients due to myotoniA: key symptom-related findings of ENSA; P66
- Late breaker: Post-authorization safety study (PASS). Mexiletine effectiveness in patients with non-dystrophic myotonia: interim analysis finding
- Sansone V. et al. Patient reported satisfaction in myotonic dystrophy management: ENSA international survey suggests benefits of Italian routine practice; P46
- 2025 Congresses
- Recursos para el paciente
- Información